Phospholamban overexpression in rabbit ventricular myocytes does not alter sarcoplasmic reticulum Ca transport

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 296, Issue 3, 2009, Pages

  Waggoner, Jason R ^a   Ginsburg, Kenneth S ^b   Mitton, Bryan ^a   Haghighi, Kobra ^a   Robbins, Jeffrey ^c   Bers, Donald M ^b   Kranias, Evangelia G ^a,d  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^d Academy of Athens Biomedical Research Foundation   (Greece)

Author keywords

Adenoviral; Calcium; Contractility

Indexed keywords

CALCIUM; ISOPRENALINE; PHOSPHOLAMBAN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SODIUM CALCIUM EXCHANGE PROTEIN; ATP2A2 PROTEIN, MOUSE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CAFFEINE; CALCIUM BINDING PROTEIN;

ADENOVIRUS; ADENOVIRUS INFECTION; ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; GENE TRANSFER; HEART MUSCLE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RABBIT; SARCOPLASMIC RETICULUM; ANIMAL; CALCIUM SIGNALING; CELL CULTURE; DRUG EFFECT; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HEART CONTRACTION; HEART VENTRICLE; METABOLISM; MOUSE; PHOSPHORYLATION; TRANSPORT AT THE CELLULAR LEVEL; UPREGULATION;

ADENOVIRIDAE; ADRENERGIC BETA-AGONISTS; ANIMALS; BIOLOGICAL TRANSPORT; CAFFEINE; CALCIUM; CALCIUM SIGNALING; CALCIUM-BINDING PROTEINS; CELLS, CULTURED; GENETIC VECTORS; HEART VENTRICLES; ISOPROTERENOL; MICE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; PHOSPHORYLATION; RABBITS; SARCOPLASMIC RETICULUM; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SODIUM-CALCIUM EXCHANGER; TRANSDUCTION, GENETIC; UP-REGULATION;

EID: 64049102341     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00272.2008     Document Type: Article

References (29)

1. Bassani JW, Bassani RA, Bers DM. Relaxation in rabbit and rat cardiac cells: species-dependent differences in cellular mechanisms. J Physiol 476: 279-293, 1994.
2. Bassani JW, Bassani RA, Bers DM. Calibration of indo and resting intracellular [Ca]i in intact rabbit cardiac myocytes. Biophys J 68: 1453-1460, 1995.
3. Bers DM. Cardiac Na/Ca exchange function in rabbit, mouse and man: what's the difference? J Mol Cell Cardiol 34: 369-373, 2002.
4. Bers DM. Cardiac excitation-contraction coupling. Nature 415: 198-205, 2002.
5. Brittsan AG, Carr AN, Schmidt AG, Kranias EG. Maximal inhibition of SERCA2 Ca(2+) affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban. J Biol Chem 275: 121292135, 2000.
6. Brittsan AG, Kranias EG. Phospholamban and cardiac contractile function. J Mol Cell Cardiol 32: 2131-2139, 2000.
7. 2+-handling in failing human myocardium. J Mol Cell Cardiol 33: 1345-1353, 2001.
8. Dash R, Kadambi V, Schmidt AG, Tepe NM, Biniakiewicz D, Gerst MJ, Canning AM, Abraham WT, Hoit BD, Liggett SB, Lorenz JN, Dorn GW 2nd, Kranias EG. Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality. Circulation 103: 889-896, 2001.
9. Davia K, Hajjar RJ, Terracciano CMN, Kent NS, Ranu HK, O'Gara P, Rosenzweig A, Harding SE. Functional alterations in adult rat myo- cytes after overexpression of phospholamban with use of adenovirus. Physiol Genomics 1: 41-50, 1999.
10. del Monte F, Harding SE, Dec GW, Gwathmey JK, Hajjar RJ. Targeting phospholamban by gene transfer in human heart failure. Circulation 105: 904-907, 2002.
11. Engelhardt S, Hein L, Dyachenkow V, Kranias EG, Isenberg G, Lohse MJ. Altered calcium handling is critically involved in the cardiotoxic effects of chronic beta-adrenergic stimulation. Circulation 109: 1154 -1160, 2004.
12. Fan GC, Chu G, Mitton B, Song Q, Yuan Q, Kranias EG. Small heat-shock protein Hsp20 phosphorylation inhibits beta-agonist-induced cardiac apoptosis. Circ Res 94: 1474-1482, 2004.
13. nd GW, MacLennan DH, Kremastinos DT, Kranias EG. Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J Clin Invest 111: 869 - 876, 2003.
14. Houser SR, Piacentino IIIV, Weisser J. Abnormalities of calcium cycling in the hypertrophied and failing heart. J Mol Cell Cardiol 32:1595-1607, 2000.
15. Hove-Madsen L, Bers DM. Passive Ca buffering and SR Ca uptake in permeablized rabbit ventricular myocytes. Am J Physiol Cell Physiol 264:C677-C686, 1993.
16. Iwanaga Y, Hoshijima M, Gu Y, Iwatate M, Dieterle T, Ikeda Y, Date MO, Chrast J, Matsuzaki M, Peterson KL, Chien KR, Ross J Jr. Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats. J Clin Invest 113:727-736, 2004.
17. Janczewski AM, Zahid M, Lemster BH, Frye CS, Gibson G, Higuchi Y, Kranias EG, Feldman AM, McTiernan CF. Phospholamban gene ablation improves calcium transients but not cardiac function in a heart failure model. Cardiovasc Res 62: 468 -480, 2004.
18. nd GW, Walsh RA, Kranias EG. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice. J Clin Invest 97: 533-539, 1996.
19. Luo W, Grupp IL, Harrer J, Ponniah S, Grupp G, Duffy JJ, Doetschman T, Kranias EG. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation. Circ Res 75: 401-409, 1994.
20. Luo W, Wolska BM, Grupp IL, Harrer JM, Haghighi K, Ferguson DG, Slack JP, Grupp G, Doetschman T, Solaro RJ, Kranias EG. Phospholamban gene dosage effects in the mammalian heart. Circ Res 78:839-847, 1996.
21. MacLennan DH, Kranias EG. Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol 4: 566-577, 2003.
22. Meyer M, Bluhm WF, He H, Post SR, Giordano FJ, Lew WY, Dillmann WH. Phospholamban-to-SERCA2 ratio controls the force-frequency relationship. Am J Physiol Heart Circ Physiol 276: H779 -H785, 1999.
23. Meyer M, Schillinger W, Pieske B, Holubarsch C, Heilmann C, Posival H, Kuwajima G, Mikoshiba K, Just H, Hasenfuss G. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardio-myopathy. Circulation 92: 778 -784, 1995.
24. Minamisawa S, Hoshijima M, Chu G, Ward CA, Frank K, Gu Y, Martone ME, Wang Y, Ross J Jr, Kranias EG, Giles WR, Chien KR. Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell 99: 313-322, 1999.
25. Pattison JS, Waggoner JR, James J, Martin L, Gulick J, Osinska H, Klevitsky R, Kranias EG, Robbins J. Phospholamban overexpression in transgenic rabbits. Transgenic Res 17: 157-170, 2008.
26. Pieske B, Beyermann B, Breu V, Loffler BM, Schlotthauer K, Maier LS, Schmidt-Schweda S, Just H, Hasenfuss G. Functional effects of endothelin and regulation of endothelin receptors in isolated human nonfailing and failing myocardium. Circulation 99: 1802-1809, 1999.
27. Schwinger RH, Munch G, Bolck B, Karczewski P, Krause EG, Erdmann E. Reduced Ca(2+)-sensitivity of SERCA2a in failing human myocardium due to reduced serine6 phospholamban phosphorylation. J Mol Cell Cardiol 31: 479-491, 1999.
28. Simmerman HKB, Jones LR. Phospholamban: protein structure, mechanism of action, and role in cardiac function. Physiol Rev 78: 921-947, 1998.
29. Ziolo MT, Martin JL, Bossuyt J, Bers DM, Pogwizd SM. Adenoviral gene transfer of mutant phospholamban rescues contractile dysfunction in failing rabbit myocytes with relatively preserved SERCA function. Circ Res 96: 815-817, 2005.